MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202411090754 A) filed by Mankind Pharma Ltd. on November 22, 2024, for An Ophthalmic Pharmaceutical Composition Of Clobetasol And Process For The Preaprartion Thereof.
Inventors include Chudasama, Vikrambhai; Kumar, Mukesh; Upadhyay, Satish Chandra; and Kumar, Anil.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to an ophthalmic pharmaceutical composition comprising clobetasol or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipient(s). Moreover, the present invention also relates to the process for the preparation of the said composition and their use for the reduction of elevated inflammatory condition of eye. Dated this, 22nd day of November, 2024 For Mankind Pharma Ltd. Dr. Anil Kumar Chief Scientific Officer
Disclaimer: Curated by HT Syndication.
